Roche Holding AG (OTCQX International Premier:RHHBY)

34.42
Delayed Data
As of 9:54am ET
 +0.04 / +0.12%
Today’s Change
32.08
Today|||52-Week Range
38.15
+1.27%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$189.7B

Company Description

Roche Holding AG is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. As a large biotech company, Roche has truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience. It is also a leader in in-vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. Twenty-four medicines developed by Roche are included in the World Health Organisation Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and chemotherapy. Roche employs over 85,000 people worldwide. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. The company was founded in 1896 and is headquartered in Basel, Switzerland.

Contact Information

Roche Holding AG
Grenzacherstrasse 124
Basel Basel-stadt (basle Town) 4070
P:(161) 687-8503
Investor Relations:

Employees

Shareholders

Mutual fund holders1.60%
Other institutional0.49%
Individual stakeholders--

Top Executives

Severin SchwanChief Executive Officer & Director
Alan HippeChief Financial & Information Technology Officer
Hyam I. LevitskyHead-Cancer Immunology Experimental Medicine
John C. ReedHead-Roche Pharma Research & Early Development
Michael D. VarneyHead-Genentech Research & Early Development

To view my watchlist

Not a member yet?

Sign up now for a free account